With a projected CAGR of 3.4% over the next decade, the market is anticipated to reach nearly USD 16.1 billion by the end of ...

Vistagen's fasedienol nasal spray is in two phase 3 trials for social anxiety disorder, with results expected in 2025. See ...

A new study finds that practicing mindfulness can be as effective as taking antidepressants to treat anxiety disorders ...

Mindfulness-based stress reduction (MBSR) was found to be as effective as the antidepressant escitalopram in reducing ...

and other social anxiety disorder symptoms. In addition to helping treat these disorders, practicing mindfulness does not produce some of the side effects known to be associated with medications ...

Miindfulness-based stress reduction may be as effective as escitalopram (Lexapro — an SSRI commonly used to treat depression ...

Scientists have found that a specific protein complex significantly influences brain connectivity and cognitive behaviors.

Schizoaffective disorder is a chronic mental health condition characterized by symptoms of both schizophrenia and mood ...

GAD is primarily treated with either therapy, medication, or a combination of both. The most common form of therapy used to treat generalized anxiety disorder is cognitive-behavioral therapy (CBT).

The Generalized Anxiety Disorder (GAD) drugs in development market research report provides comprehensive information on the therapeutics under development for Generalized Anxiety Disorder (GAD), ...

By generating mice with genetic mutations that disrupt the brain's TrkC-PTP protein complex, researchers find a key way that brain cells communicate.